[go: up one dir, main page]

UY31887A - Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión - Google Patents

Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión

Info

Publication number
UY31887A
UY31887A UY0001031887A UY31887A UY31887A UY 31887 A UY31887 A UY 31887A UY 0001031887 A UY0001031887 A UY 0001031887A UY 31887 A UY31887 A UY 31887A UY 31887 A UY31887 A UY 31887A
Authority
UY
Uruguay
Prior art keywords
dronedarone
cardioversion
prevention
preparation
medicinal product
Prior art date
Application number
UY0001031887A
Other languages
English (en)
Inventor
Van Eickels Martin
Gaudin Christophe
Hamdani Nacera
Davide Radzik
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31887(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY31887A publication Critical patent/UY31887A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión.
UY0001031887A 2008-06-10 2009-06-10 Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión UY31887A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6026008P 2008-06-10 2008-06-10
EP08290532A EP2133075A1 (en) 2008-06-10 2008-06-10 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion

Publications (1)

Publication Number Publication Date
UY31887A true UY31887A (es) 2010-01-29

Family

ID=39739955

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031887A UY31887A (es) 2008-06-10 2009-06-10 Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión

Country Status (25)

Country Link
US (1) US20110166221A1 (es)
EP (2) EP2133075A1 (es)
JP (1) JP2011522875A (es)
KR (1) KR20110026421A (es)
CN (1) CN102056602A (es)
AR (1) AR072070A1 (es)
AU (1) AU2009259008A1 (es)
BR (1) BRPI0915015A2 (es)
CA (1) CA2727210A1 (es)
CL (1) CL2010001421A1 (es)
CO (1) CO6280478A2 (es)
CR (1) CR11755A (es)
DO (1) DOP2010000361A (es)
EA (1) EA201071412A1 (es)
EC (1) ECSP10010661A (es)
IL (1) IL209790A0 (es)
MA (1) MA32461B1 (es)
MX (1) MX2010013700A (es)
NI (1) NI201000212A (es)
PE (1) PE20110066A1 (es)
SV (1) SV2010003753A (es)
TW (1) TW201002314A (es)
UY (1) UY31887A (es)
WO (1) WO2009150534A1 (es)
ZA (1) ZA201009171B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100135909A (ko) 2008-04-17 2010-12-27 사노피-아벤티스 심혈관성 입원 또는 사망을 예방하는데 사용하기 위한 약제의 제조에 있어서의 드로네다론의 용도
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN104721547A (zh) * 2015-03-14 2015-06-24 包汉雨 一种促进房颤患者复律的中药组合物

Also Published As

Publication number Publication date
CN102056602A (zh) 2011-05-11
CR11755A (es) 2011-01-10
DOP2010000361A (es) 2010-12-31
NI201000212A (es) 2011-04-27
CL2010001421A1 (es) 2011-05-13
ZA201009171B (en) 2012-03-28
EA201071412A1 (ru) 2011-06-30
IL209790A0 (en) 2011-02-28
CO6280478A2 (es) 2011-05-20
TW201002314A (en) 2010-01-16
JP2011522875A (ja) 2011-08-04
AU2009259008A1 (en) 2009-12-17
EP2133075A1 (en) 2009-12-16
BRPI0915015A2 (pt) 2015-10-27
ECSP10010661A (es) 2011-01-31
EP2303259A1 (en) 2011-04-06
WO2009150534A1 (en) 2009-12-17
MX2010013700A (es) 2011-02-23
CA2727210A1 (en) 2009-12-17
KR20110026421A (ko) 2011-03-15
US20110166221A1 (en) 2011-07-07
SV2010003753A (es) 2011-03-15
MA32461B1 (fr) 2011-07-03
PE20110066A1 (es) 2011-02-16
AR072070A1 (es) 2010-08-04

Similar Documents

Publication Publication Date Title
DOP2010000299A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
CL2012000319A1 (es) Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
NI201000211A (es) Dronedarona para la prevención de la fibrilación auricular permanente.
CL2007002446A1 (es) Compuestos derivados de morfolino pirimidina; composicion farmaceutica; y su uso para preparar un medicamento para producir un efecto antiproliferante.
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
NI201000212A (es) Dronedarona para la prevención de la cardioversión.
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
EA200900958A1 (ru) Препарат невирапина пролонгированного высвобождения
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
UA105944C2 (uk) Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0516464B8 (pt) método para a preparação de um produto farmacêutico
BR112014007022A8 (pt) composição farmacêutica, método de melhoria da absorção no intestino delgado e uso de uma composição farmacêutica.
BR112013010061A2 (pt) "composição farmacêutica, composição e uso"
UY31767A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad
ECSP10010540A (es) Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
TR200907915A2 (tr) Kuru toz formunda farmasötik bileşim.
TR200805337A2 (tr) Valsartan etkin maddesini içeren yeni oral farmasötik formülasyonlar
RU2011145777A (ru) Лекарственное средство, обладающее ранозаживляющей, противовоспалительной активностью

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140602